Medicine and Dentistry
COVID-19
100%
Patient
82%
Ulcerative Colitis
75%
Adaptation
50%
Inflammatory Bowel Disease
44%
Inpatient
41%
Endoscopy
31%
Therapeutic Procedure
30%
Severe Acute Respiratory Syndrome Coronavirus 2
29%
Quality of Care
25%
Assessment
25%
Personalized Medicine
25%
Patient with Inflammatory Bowel Disease
25%
Patient Referral
17%
Immunosuppressive Treatment
15%
Combination Therapy
11%
Pneumonia
11%
Rescue Therapy
10%
Mucosa
10%
Leukocyte
10%
Steroid
9%
Biological Product
8%
Colectomy
8%
Hospital
8%
Surgery
7%
Primary Health Care
7%
Infection
7%
Medication
6%
Social Distancing
6%
Coronavirinae
6%
Immunosuppressive Drug
6%
Hydrocortisone
5%
Anticoagulation
5%
Azathioprine
5%
Infliximab
5%
Maintenance Therapy
5%
Nurse Consultant
5%
Intestine Mucosa
5%
Tumor Necrosis Factor
5%
Integrin
5%
Side Effect
5%
Young Adult
5%
Gut
5%
Serositis
5%
Clinical Trial
5%
Spontaneous Remission
5%
Monoclonal Antibody
5%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
51%
Pandemic
28%
Mercaptopurine
26%
Case-Control Study
25%
Ulcerative Colitis
25%
Clinical Trial
12%
Biological Product
11%
Monotherapy
8%
Tolerability
8%
Coronavirinae
6%
Immunosuppressive Agent
6%
Immunology and Microbiology
Antigen
25%
Innate Immune System
25%
Agonist
25%
T Lymphocyte Antigen
25%
Adaptive Immune System
25%
Intraepithelial Lymphocyte
10%
Mouse
7%